Research focuses on mechanistic behavior under controlled conditions rather than applications involving growth factors or enhancement
DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system
Most people notice a difference within 3 to 4 weeks of regular use
The growth hormone axis is regulated by multiple peptides and hormones, primarily GHRH and ghrelin
Zabidi NA, Ishak NA, Hamid M, Efliza AS
From then, the body will start to burn through existing fat stores